Clinical Trial Update: Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update investigating nilotinib with chemotherapy for chronic myeloid leukemia in myeloid blast crisis or untreated adult acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia in Myeloid Blast Crisis

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Ulsan University Hospital | Conditions: Chronic Myeloid Leukemia in Myeloid Blast Crisis, Untreated Adult Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN